Modulating HSF1 levels impacts expression of the estrogen receptor α and antiestrogen response

Area of Science:

• Molecular Biology
• Cancer Biology
• Endocrinology

Background:

• Master transcription factors regulate cellular functions and gene expression.
• Steroid nuclear receptors, like estrogen receptor alpha (ERα), are crucial in hormone-dependent cancers.
• Endocrine therapies targeting ERα are standard, but resistance is a significant clinical challenge.

Purpose of the Study:

• To investigate the role of heat shock factor 1 (HSF1) in the development of antiestrogen resistance in breast cancer.
• To elucidate the mechanism by which HSF1 influences ERα activity and endocrine response.
• To evaluate HSF1 inhibition as a therapeutic strategy for resistant breast cancers.

Main Methods:

• Analysis of HSF1 levels in breast cancer cells exhibiting antiestrogen resistance.
• Experimental manipulation of HSF1 expression (overexpression and reduction) in cell models.
• Assessment of ERα protein levels, ERα-target gene expression, and cellular response to antiestrogens.
• Evaluation of combination therapy with HSF1 inhibitors and antiestrogens.

Main Results:

• High HSF1 levels correlate with antiestrogen resistance in breast cancer.
• HSF1 overexpression causes ERα degradation and reduces ERα-dependent gene expression.
• Reducing HSF1 levels restores ERα expression and antiestrogen sensitivity.
• Combined inhibition of HSF1 and antiestrogens shows promise in resistant models.

Conclusions:

• Elevated HSF1 promotes endocrine resistance by disrupting the ERα transcriptional program.
• Targeting HSF1 represents a viable therapeutic strategy to overcome antiestrogen resistance in breast cancer.
• Understanding the HSF1-ERα axis offers new avenues for treating hormone-dependent cancers.